Skip to content

Ten-year effects of the medical support system of Frontier of Renal Outcome Modifications in Japan

Ten-year effects of the medical support system of Frontier of Renal Outcome Modifications in Japan - FROM-J 10

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000035702
Enrollment
2300
Registered
2019-01-28
Start date
2019-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic kidney disease

Interventions

None listed

Sponsors

University of Tsukuba
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with CKD stage 1,2,4 or 5. 2. Patients with CKD stage 3 who have proteinuria, also with diabetes mellitus or hypertension

Exclusion criteria

Exclusion criteria: 1. Patients who did not attend FROM-J study. 2. Patients who attend FROM-J study but did not consent to attend follow-up study.

Design outcomes

Primary

MeasureTime frame
multi end points: cardiovascular disease,renal replacement therapy and 50% reduction rate of eGFR.

Secondary

MeasureTime frame
1.survival rate 2. yearly decline of eGFR 3. coalition between general physician and nephrologist

Countries

Japan

Contacts

Public ContactChie Saito

University of Tsukuba Department of Nephrology,Division of Clinical Medicine, Faculty of Medicine

reach-j@md.tsukuba.ac.jp029-853-3202

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026